Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) protein
US-11130769-B2 · Sep 28, 2021 · US
condensed with carbocyclic rings or ring systems
condensed with carbocyclic rings or ring systems · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D267/12 |
| Official title | condensed with carbocyclic rings or ring systems |
| Display label | condensed with carbocyclic rings or ring systems |
| Total patents | 77 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly growing.
| Year | Patents |
|---|---|
| 2015 | 2 |
| 2016 | 5 |
| 2018 | 1 |
| 2019 | 42 |
| 2020 | 8 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
MCL-1 inhibitors
US-10988451-B2 · Apr 27, 2021 · US
Mcl-1 inhibitors
US-2020331870-A1 · Oct 22, 2020 · US
MCL-1 inhibitors
US-10703733-B2 · Jul 7, 2020 · US
Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) Protein
US-2020148705-A1 · May 14, 2020 · US
3-alkyl bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2020055830-A1 · Feb 20, 2020 · US
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2020048211-A1 · Feb 13, 2020 · US
3-aryl-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2020048212-A1 · Feb 13, 2020 · US
Anthraquinone analogs and methods of making and using thereof
US-10544090-B2 · Jan 28, 2020 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
US-2020002298-A1 · Jan 2, 2020 · US
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10513501-B2 · Dec 24, 2019 · US
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10501424-B2 · Dec 10, 2019 · US
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10494354-B2 · Dec 3, 2019 · US
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10494353-B2 · Dec 3, 2019 · US
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10494352-B2 · Dec 3, 2019 · US
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10494351-B2 · Dec 3, 2019 · US
Mcl-1 inhibitors
US-2019352271-A1 · Nov 21, 2019 · US
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10479772-B2 · Nov 19, 2019 · US
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10472337-B2 · Nov 12, 2019 · US
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
US-10464910-B2 · Nov 5, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D267/12?
- CPC C07D267/12 is the Cooperative Patent Classification code for “condensed with carbocyclic rings or ring systems.”
- How many patents are filed under CPC C07D267/12 (condensed with carbocyclic rings or ring systems)?
- Our database includes 77 publications tagged with this CPC code.
- Is patent activity under CPC C07D267/12 growing?
- Publication counts under this code: 1 in 2024 vs 5 in 2025 (latest complete years).